炎症性乳腺癌:流行病学数据和治疗结果
Hamouda Boussen1, Yosra Berrazaga2, Sherif Kullab3
1Department of Medical Oncology, University Hospital A Mami, Ariana, Tunis, Tunisia; Inflammatory breast cancer international consortium (IBC-IC), New York, NY, United States.
International review of cell and molecular biology
|April 18, 2024
概括
炎症性乳腺癌 (IBC) 具有侵略性,在北非发病率较高. 改进的诊断和多学科护理已经减少了全球IBC的流行率和死亡率.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 炎症性乳腺癌 (IBC) 是一种具有明显地理变异的侵袭性恶性瘤,特别是在北非的发病率高于西方国家.
- IBC呈现出快速症状进展 (3-6个月),并与年轻的年龄 (<50岁) 和积极的临床/分子亚型 (60%是三阴性或HER2+) 相关.
结论:
- 尽管它具有攻击性,但诊断和治疗方面的进步使炎症性乳腺癌患者的治疗结果得到改善.
- 持续的研究和合作努力对于进一步降低全球IBC患病率和死亡率至关重要.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345


